Differential regulation of the TRH gene promoter by triiodothyronine and dexamethasone in pancreatic islets

in Journal of Endocrinology
Authors:
P Fragner
Search for other papers by P Fragner in
Current site
Google Scholar
PubMed
Close
,
SL Lee
Search for other papers by SL Lee in
Current site
Google Scholar
PubMed
Close
, and
S Aratan de Leon
Search for other papers by S Aratan de Leon in
Current site
Google Scholar
PubMed
Close
Free access

Sign up for journal news

TRH was initially found in the hypothalamus and regulates TSH secretion. TRH is also produced by insulin-containing beta-cells. Endogenous TRH positively regulates glucagon secretion and attenuates pancreatic exocrine secretion. We have previously shown that triiodothyronine (T(3)) down-regulates pre-pro-TRH gene expression in vivo and in vitro. The present study was designed to determine the initial impact of T(3) on rat TRH gene promoter and to compare this effect with that of dexamethasone (Dex). Primary islet cells and neoplastic cells (HIT T-15 and RIN m5F) were transiently transfected with fragments of the 5'-flanking sequence of TRH fused to the luciferase reporter gene. The persistence of high TRH concentrations in fetal islets in culture, probably due to transactivating factors, allowed us to explore how T(3) and Dex regulate the TRH promoter activity in transfected cells and whether the hormone effect is dependent on the cell type considered. TRH gene promoter activity is inhibited by T(3) in primary but not neoplastic cells and stimulated by Dex in both primary and neoplastic cells of islets. These findings validate previous in vivo and in vitro studies and indicate the transcriptional impact of these hormones on TRH gene expression in the pancreatic islets.

 

  • Collapse
  • Expand